The Food and Drug Administration (FDA) on Wednesday warned the public and health professionals against counterfeit anti-rabies vaccines circulating in the market in the midst of dwindling supply of anti-rabies vaccines in the country.
“The FDA, together with the Marketing Authorization Holder (MAH), GlaxoSmithKline Philippines Inc. (GSK), have verified that the above-mentioned sample drug product [Rabipur], is counterfeit,” said FDA in its Advisory No. 2018-138.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.